DRU Highlights
Our paper The multi-factorial nature of clinical multidrug resistance in cancer was selected by ASPIC (Portuguese Association of Cancer Research),…
Special
issues
edited by
our scientists
We aim to improve both
the diagnosis and therapy
of multidrug resistant (MDR)
solid tumours.
Welcome!
Looking for
the future
Fighting together
against multidrug
resistant tumours
Stronger together
Welcome to
our community